Skip to main content
ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
0.170
-0.008 (-4.72%)
At close: Apr 26, 2024, 3:27 PM
0.171
+0.001 (0.83%)
After-hours: Apr 26, 2024, 4:00 PM EDT

ReShape Lifesciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for RSLS.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for RSLS.

Recommendation Trends

Rating Mar '22Apr '22May '22
Strong Buy 110
Buy 000
Hold 000
Sell 000
Strong Sell 000
Total 110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Ben Haynor
Alliance Global Partners
 Alliance Global Partners
Strong Buy
Maintains
$275 → $233
 Strong Buy Maintains $275 → $233 +136,987.26% May 26, 2022
Anthony Vendetti
Maxim Group
 Maxim Group
Strong Buy
Initiates
n/a
 Strong Buy Initiates n/a n/a Oct 8, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
10.19M
from 8.68M
Increased by 17.47%
Revenue Next Year
12.23M
from 10.19M
Increased by 20.00%
EPS This Year
-0.46
from -1.91
EPS Next Year
-0.37
from -0.46
Year 2019202020212022202320242025
Revenue
3.28M11.30M13.60M11.24M8.68M10.19M12.23M
Revenue Growth
-63.95%244.38%20.36%-17.35%-22.79%17.47%20.00%
EPS
-754.50-277.00-288.97-108.90-1.91-0.46-0.37
EPS Growth
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 10.5M 12.6M
Avg 10.2M 12.2M
Low 9.8M 11.8M

Revenue Growth

Revenue Growth 20242025
High
20.9%
23.5%
Avg
17.5%
20.0%
Low
12.9%
15.3%

EPS Forecast

EPS 20242025
High -0.47 -0.38
Avg -0.46 -0.37
Low -0.44 -0.35

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.